Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Lipid safety of tenofovir alafenamide during 96-week trea... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Lipid safety of tenofovir alafenamide during 96-week treatment in treatment-naive chronic hepatitis B patients
0
Authors
Wenjuan Zhao
11 more
Wenjuan Zhao
•
Yi Liu
9 more
•
Feng Ye
Published
June 4, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Frontiers in Medicine
Topics
Medicine
Epidemiology
Immunology
Internal Medicine
Endocrinology
Show all topics
DOI
10.3389/fmed.2024.1399665
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Frontiers in Medicine
Topics
Medicine
Epidemiology
Immunology
Internal Medicine
Endocrinology
Show all topics
DOI
10.3389/fmed.2024.1399665
License
CC-BY
Other Formats
PDF
